Don't Jump to a CGRP Antagonist for Migraine Prophylaxis

You'll see two new biologics to PREVENT migraine in adults, Ajovy (uh-JOH-vee, fremanezumab) and Emgality (em-GAL-ih-tee, galcanezumab).

They'll join Aimovig (erenumab)...the first calcitonin gene-related peptide blocker, or CGRP antagonist. Blocking CGRP limits vasodilation.

All are once-monthly, self-administered subcutaneous injections...or Ajovy can be given as 3 injections once every 3 months. Aimovig is an auto-injector...Ajovy is a prefilled syringe...Emgality is a pen.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote